We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+5.86%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$6.68B
AUM Growth
+$4.27B
Cap. Flow
+$4.13B
Cap. Flow %
61.82%
Top 10 Hldgs %
13.41%
Holding
935
New
392
Increased
185
Reduced
81
Closed
253

Top Buys

Rank Stock Value
1
TFX icon
Teleflex
TFX
+$84.6M
2
MCD icon
McDonald's
MCD
+$79.3M
3
BBY icon
Best Buy
BBY
+$78M
4
SPGI icon
S&P Global
SPGI
+$75.1M
5
DGX icon
Quest Diagnostics
DGX
+$73.6M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18.81%
2 Healthcare 17.75%
3 Technology 12.65%
4 Financials 8.92%
5 Consumer Staples 7.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HEI.A icon
751
HEICO Corp Class A
HEI.A
$35.4B
-8,398
Closed -$477K
HFWA icon
752
Heritage Financial
HFWA
$1.24B
-17,700
Closed -$542K
HLIO icon
753
Helios Technologies
HLIO
$2.64B
-6,200
Closed -$332K
HOV icon
754
Hovnanian Enterprises
HOV
$785M
-1,249
Closed -$57K
HRTX icon
755
Heron Therapeutics
HRTX
$86.3M
-12,100
Closed -$334K
HSIC icon
756
Henry Schein
HSIC
$9.74B
-4,980
Closed -$263K
HST icon
757
Host Hotels & Resorts
HST
$16.8B
-56,968
Closed -$1.06M
IBN icon
758
ICICI Bank
IBN
$106B
-1,021,487
Closed -$9.04M
IEMG icon
759
iShares Core MSCI Emerging Markets ETF
IEMG
$149B
-44,983
Closed -$2.63M
INGN icon
760
Inogen
INGN
$167M
-3,878
Closed -$476K
IOVA icon
761
Iovance Biotherapeutics
IOVA
$2.23B
-28,991
Closed -$490K
IPGP icon
762
IPG Photonics
IPGP
$3.89B
-2,422
Closed -$565K
IRTC icon
763
iRhythm Holdings
IRTC
$3.59B
-7,200
Closed -$453K
JBHT icon
764
JB Hunt Transport Services
JBHT
$27.1B
-4,490
Closed -$526K
JNJ icon
765
Johnson & Johnson
JNJ
$635B
-20,602
Closed -$2.64M
JPM icon
766
JPMorgan Chase
JPM
$939B
-91,260
Closed -$10M
KN icon
767
Knowles
KN
$3.22B
-56,896
Closed -$716K
KOF icon
768
Coca-Cola Femsa
KOF
$21.6B
-7,330
Closed -$487K
KURA icon
769
Kura Oncology
KURA
$922M
-11,000
Closed -$206K
LEN icon
770
Lennar Class A
LEN
$20.4B
-39,704
Closed -$2.27M
LH icon
771
Labcorp
LH
$24.3B
-4,654
Closed -$647K
LILAK icon
772
Liberty Latin America Class C
LILAK
$1.5B
-71,306
Closed -$1.17M
LNTH icon
773
Lantheus
LNTH
$6.82B
-14,500
Closed -$231K
LOMA
774
Loma Negra
LOMA
$1.33B
-21,400
Closed -$456K
LPG icon
775
Dorian LPG
LPG
$1.94B
-39,500
Closed -$296K

Similar funds

Marshall Wace's Q2 2018 Portfolio in Review

As of Q2 2018, Marshall Wace held 935 positions worth $6.68B, up 177% from $2.41B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Marshall Wace deployed $4.13B of net new capital in Q2 2018, opening 392 new positions and adding to 185 existing holdings. Its largest new stake was TSMC: 1,597,877 shares worth $58.4M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Alibaba, an estimated $79.1M trimmed.

  • Marshall Wace's largest Q2 2018 buy was TSMC: 1,597,877 shares worth $58.4M.
  • Marshall Wace added most to Teleflex in Q2 2018, an estimated $84.6M increase.
  • Marshall Wace's biggest Q2 2018 reduction was Alibaba, cutting an estimated $79.1M.
  • Marshall Wace fully exited Monsanto Co in Q2 2018, selling an estimated $59.9M.
  • Marshall Wace's ten largest holdings make up 13% of its $6.68B portfolio in Q2 2018.
  • Marshall Wace opened 392 new positions and closed 253 in Q2 2018.
  • Marshall Wace's portfolio value rose 177% quarter-over-quarter to $6.68B.

Based on Marshall Wace's 13F filing for Q2 2018, filed 14 Aug 2018.